Tag: Amphera

Cell and Gene Therapy, Clinical Trials, Industry, Research and Development

Positive results for Amphera’s MesoPher cell therapy

December 12, 2022

Via: Pharma Times

Amphera – a company developing MesoPher cell therapy to treat cancer – has delivered positive results from its phase 2 Reactive trial and phase 2/3 DENIM trial. During the phase 2 Reactive study, patients with resected pancreatic cancer who had […]